Page last updated: 2024-08-22

mopidamol and Ovarian Neoplasms

mopidamol has been researched along with Ovarian Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Grönroos, M; Kauppila, A; Kuoppala, T; Nieminen, U; Väyrynen, M	1

Trials

1 trial(s) available for mopidamol and Ovarian Neoplasms

Article	Year
Placebo-controlled study on the efficacy of the pyrimido-pyrimidine derivative RA 233 in ovarian cancer. Gynecologic oncology, 1990, Volume: 36, Issue:2 Topics: Combined Modality Therapy; Female; Humans; Mopidamol; Neoplasm Metastasis; Neoplasm Staging; Ovarian Neoplasms; Placebos; Prognosis; Prospective Studies; Pyrimidines; Randomized Controlled Trials as Topic; Risk Factors; Statistics as Topic; Survival	1990

Article

Year

Placebo-controlled study on the efficacy of the pyrimido-pyrimidine derivative RA 233 in ovarian cancer.

Gynecologic oncology, 1990, Volume: 36, Issue:2

Topics: Combined Modality Therapy; Female; Humans; Mopidamol; Neoplasm Metastasis; Neoplasm Staging; Ovarian Neoplasms; Placebos; Prognosis; Prospective Studies; Pyrimidines; Randomized Controlled Trials as Topic; Risk Factors; Statistics as Topic; Survival

1990